Alcon Inc. (ALC) CEO David Endicott on Q3 2021 Results - Earning Call TranscriptSeeking Alpha • 11/10/21
Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021Business Wire • 11/08/21
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology PortfolioBusiness Wire • 11/08/21
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice NeedsBusiness Wire • 11/01/21
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye CareBusiness Wire • 10/14/21
Alcon Inc. (ALC) CEO David Endicott on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/18/21
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact LensBusiness Wire • 08/11/21
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021Business Wire • 07/22/21
Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021Business Wire • 06/07/21
Alcon Inc. (ALC) CEO David Endicott on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/05/21